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In recent years gene regulatory networks (GRNs) have attracted a lot of interest and many
methods have been introduced for their statistical inference from gene expression data.
However, despite their popularity, GRNs are widely misunderstood. For this reason, we
provide in this paper a general discussion and perspective of gene regulatory networks.
Specifically, we discuss their meaning, the consistency among different network inference
methods, ensemble methods, the assessment of GRNs, the estimated number of existing
GRNs and their usage in different application domains. Furthermore, we discuss open
questions and necessary steps in order to utilize gene regulatory networks in a clinical
context and for personalized medicine.
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1. INTRODUCTION
About 15 years ago inference of large-scale gene regulatory net-
works (GRNs) was made possible thanks to the availability of
high-throughput gene expression data. Within this time, many
different methods have been developed (Liang et al., 1998; Butte
et al., 2000; Friedman, 2004; Wille et al., 2004; Zhang et al.,
2011) and used to enhance our understanding of diseases (Basso
et al., 2005; Madhamshettiwar et al., 2012). However, despite
their widespread usage in current biomedical research, there is
still much confusion about the basic meaning of GRNs, ways of
assessment, and possible application areas.
In this paper, we aim to clarify some of these problems and
also provide a discussion of important next steps in order to bring
gene regulatory networks closer to the clinical and medical appli-
cation. Furthermore, we add some recommendations we consider
important to make GRNs more popular among biologists and
clinicians, as they require a dedicated platform for accessing and
analyzing inferred gene regulatory networks.
2. HOW DOWE CALL NETWORKS INFERRED FROM GENE
EXPRESSION DATA
For reasons of clarity, we first define what we mean by a gene
regulatory network.
Definition 1. We call a network that has been inferred from
gene expression data a “gene regulatory network,” briefly denoted
as GRN.
From the above definition one can see that we are assuming
a statistical perspective placing the data in the center of focus.
Due to the nature of gene expression data, providing informa-
tion about the abundance of mRNAs only rather than binding
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information, gene regulatory networks defined in the above
sense provide information about regulatory interactions between
regulators and their potential targets; gene-gene interactions,
and potential protein-protein interactions (e.g., in a complex)
(de Matos Simoes et al., 2013a).
There are many examples where such networks have been
studied (Margolin et al., 2006; Werhli et al., 2006; Meyer et al.,
2008; Stolovitzky et al., 2009; Emmert-Streib et al., 2012); see
Table 1 for a brief overview. So far there is no generally adopted
parlance to name such inferred networks, but the term gene reg-
ulatory network (Hecker et al., 2009) is frequently used and will
also be utilized in this paper.
For completeness, we would like to mention that there are
a variety of conceptually different approaches to infer networks
and we would like to refer the reader to the review articles
by Lee et al. (2009); Markowetz et al. (2007) for a thorough
discussion.
3. IS THERE JUST ONE “RIGHT” METHOD?
In the last years, there have been many network inference meth-
ods introduced and many comparisons have been conducted
(Akutsu et al., 1999; Margolin et al., 2006; Werhli et al., 2006;
Meyer et al., 2008; Stolovitzky et al., 2009; Emmert-Streib et al.,
2012). As it seems, the results of such technical comparisons
depend crucially on the studied conditions, including; type of the
data (simulated, real), size of the network, number of samples,
amount of noise, experimental design (observational, experimen-
tal, interventional), type of the underlying interaction structure
(scale-free, random, small-world), error measure (global, local),
among others. For this reason it is unlikely that there is one
“right” method that fits all different biological, technical and
experimental design conditions best.
However, if one asks less technical and more biological ques-
tions about the meaning of the inferred networks, i.e., by eval-
uating the biological consistency of inferred networks resulting
from different network inference methods, there is supporting
evidence that the differences might not be that large, as recently
Table 1 | Brief overview of statistical network inference methods that
have been introduced in recent years and the key methods (second
column) on which the inference algorithms are based on to estimate
interactions.
Name Method References
RN Mutual information Butte and Kohane, 2000
Aracne Mutual information, DPI Margolin et al., 2006
CLR Mutual information with
background
Faith et al., 2007
C3Net Maximal mutual information Altay and
Emmert-Streib, 2010a
BC3Net Bagging C3Net de Matos Simoes and
Emmert-Streib, 2012
GENIE3 Regression Huynh-Thu et al., 2010
GGM Full partial correlation Wille et al., 2004
MRNet Conditional mutual information Meyer et al., 2008
MI3 Three-way mutual information Luo et al., 2008
demonstrated for C3Net, BC3Net and Aracne (de Matos Simoes
et al., 2013b). Hence, it is unlikely that there is just one method
that outperforms all others for all conditions, but a number of
methods result in an overlapping spectrum having the potential
to infer similar biological information.
4. ENSEMBLE METHODS
A recent trend in the field of biological network inference is the
use of ensemble methods (Zhang and Singer, 2010) to improve
their stability and accuracy. Ensemble methods have been popu-
larized by Leo Breiman as exemplified by random forest classifiers
(Breiman, 2001) that have at their heart bagging (Breiman, 1996).
Briefly, the underlying idea is to (1) bootstrap a given data set,
(2) apply a network inference method, and (3) aggregate all sep-
arate outcomes into a final result. Here, it is possible to apply for
each bootstrap data set the same inference method or different
methods, leading to the distinction between homogeneous and
heterogeneous ensemble methods. Examples for network infer-
ence methods that are based on this principle are (Huynh-Thu
et al., 2010; de Matos Simoes and Emmert-Streib, 2012; Marbach
et al., 2012).
Although ensemble approaches to network inference are com-
putationally intensive, they have the clear advantage of being
straightforwardly and efficiently implemented in large computer
cluster. Indeed, if one runs an ensemble of size B on a computer
cluster with B nodes, the computation time for the whole ensem-
ble is (about) the same as for just one method run on one desktop
computer.
5. ASSESSING INFERRED NETWORKS
The assessment of inferred networks is an important and com-
plicated topic. The reason for this is that networks are high-
dimensional, structured objects that enable modeling of diverse
aspects of biological systems. There are two main issues one has
to face when assessing the quality of inferred biological networks:
(I) the definition of a set of “true” interactions, referred to as
gold standard and (II) the choice of statistical measures to quan-
titatively assess the quality of networks using this gold standard.
The former issue is usually addressed by using known interac-
tions from research articles (Mostafavi et al., 2008; Haibe-Kains
et al., 2012) and structured biological databases such as KEGG
(Kanehisa and Goto, 2000) or I2D (Brown and Jurisica, 2005).
The main disadvantage of this approach is that, although the set
of known interactions might be quite large, many of them might
not be relevant to the biological conditions under investigation.
For this reason, it is also important to note that the standardized
reporting of such contextual information is crucial for comparing
causal and correlative relationships between molecular entities
meaningfully. Examples for such are endeavors that provide com-
puter processable languages are BEL, PySB, and BCML (Slater,
2014).
As an alternative, several research groups performed multiple
perturbations of the biological system under study (cancer cell
lines for instance) to measure their effects and subsequently
validate their inferred networks (Frohlich et al., 2008; Olsen
et al., 2014). This experimental design, although significantly
more lengthy and costly, enables to validate inferred interactions
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in conditions that are identical or closely mimic those used
for network inference. As an example, Olsen et al. knocked
down 8 genes in the RAS signaling pathway in colorectal can-
cer cell lines to quantitatively assess the quality of gene inter-
action networks built from expression data of human colon
tumors.
Given a set of known interactions, one can use traditional sta-
tistical error measures, such as F-score or AUC-ROC (area under
the receiver operating characteristics curve). These measures can
be used to assess the quality of networks at the global-level (for
the network as a whole) or at the edge-level (for each individual
edge) or for many intermediate-levels (for instance for network-
motifs); see Altay and Emmert-Streib (2010b); Emmert-Streib
and Altay (2010). That means, already for generic statistical error
measures there are many different levels that can be assessed.
Furthermore, real biological data and simulated data can, and
should, be used for the assessment of networks. For real biolog-
ical data this allows to assess the biological relevance of inferred
networks, e.g., by using GO or KEGG, and simulated data enable
a detailed analysis of any technical aspect. In general, one should
use a large variety of quality and error measures on a routine way.
Unfortunately, standards are currently not available, but would
need to be developed.
6. HOWMANY GENE REGULATORY NETWORKS EXIST?
It is generally acknowledged that a phenotype is an emergent
property of genotype-environment interactions. Specifically, a
phenotype results from molecular and cellular activity patterns
from genotype-environment interactions. This implies that each
observable phenotype is associated with phenotype-specific gene
networks, because without changing molecular interactions a
phenotype cannot change; this concept is illustrated in Figure 1.
In this figure, gene networks can be seen as a bottleneck between
the genotype and the phenotype with respect to their coupling.
That means every change on the genotype level that will result in
a change of the phenotype will also inevitably lead to a change in
the gene network structure as mediator between both levels.
However, since gene networks refer to all possible types of
molecular networks, including the transcriptional regulatory net-
work, protein interaction network, metabolic network, gene reg-
ulatory network and interactions between these networks, it is
less clear which of these networks, or all of them, are actually
changed.Moreover, because a gene regulatory network can poten-
tially represent many types of physical biochemical interactions
among genes and gene products (de Matos Simoes et al., 2013a)
it can be expected that gene regulatory networks are highly phe-
notype specific (Schadt, 2009; Emmert-Streib and Glazko, 2011).
FIGURE 1 | Schematic overview of the general role gene networks play in understanding phenotypes.
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Establishing such relationships will therefore be a complex task,
but also provides an opportunity to catalog phenotypes quantita-
tively. An example for the analysis of tissue-specific networks can
be found in Guan et al. (2012) where 107 tissue specific network
have been studied. Currently, the number of GRNs is difficult to
estimate but based on these preliminary results one can hypoth-
esize that there are more than 200 different GRNs for Human
alone, because this corresponds about to the number of differ-
ent cell types. However, also pathological cells manifesting tumors
have their own characteristic networks (Emmert-Streib et al.,
2014) implying that there are probably thousands of different
gene networks in Human.
7. USAGE OF GENE REGULATORY NETWORKS
It is important to emphasize that the inference of gene regulatory
networks is not the final result, but these networks are supposed
to help in solving a number of different biological and biomedical
problems.
7.1. CAUSAL MAP OF MOLECULAR INTERACTIONS
Maybe the most frequently named use of gene regulatory net-
works is to serve as a “map” or a “blueprint” of molecular
interactions. In this respect such a network can be used to derive
novel biological hypothesis about molecular interactions, e.g., for
the transcription regulation of genes, which can then be investi-
gated in wet lab experiments by using, e.g., ChIP-chip and gene
expression experiments (Bussemaker et al., 2001; Basso et al.,
2005). In such a case GRNs represent causal biochemical inter-
actions because the predicted links are supposed to correspond to
actual physical binding events between molecules. It is important
to note that the inference of such causal interactions between gene
products is a challenging task, because it goes beyond the mere
association between such entities that would include also indi-
rect relations/interactions involving intermediate gene products
as well. However, despite the limitations of association networks
it is interesting to note that also such networks capture valuable
biological information (Butte et al., 2000).
An important aspect of this application is that the GRNs
represent statistically significant predictions of molecular inter-
actions obtained from large-scale data. Given the very large num-
ber of potential interactions between ∼20, 000 genes in Human
and∼6000 gene in yeast, the GRNs are of tremendous help in nar-
rowing these numbers down to potential interactions for which
statistical support is available. Overall, this enables more effective
experiments by an adopted experimental design.
7.2. EXPERIMENTAL DESIGN AND PERTURBATION EXPERIMENTS
An under appreciated applicability of gene regulatory networks
is to use these for guiding the experimental design of new
experiments. Specifically, many high-throughput experiments
are screening experiments generating observational data. That
means, these experiments are not controlled by establishing con-
ditions that enhance molecular target processes to improve the
signal strength of these, but they merely “observe” the state of the
systems as it is, without interventions or perturbations. A down-
side of such screening experiments is that the signal about, e.g.,
certain pathways, may be too low to be inferable by statistical
means. However, using prior knowledge about “partial” gene reg-
ulatory networks inferred from such observational datamay allow
to overcome these obstacles systematically and help in designing
perturbation or intervention experiments to stimulate the molec-
ular system purposefully. That means by identifying the parts of
the molecular system that are not well detected, based on inferred
networks, dedicated perturbations can be constructed to boost
their active responses.
7.3. NETWORKS AS BIOMARKERS
In recent studies, it has been argued that (sub-)networks could
also be used as biomarkers, e.g., for diagnostic, predictive or
prognostic purposes (Chuang et al., 2007; Ben-Hamo and Efroni,
2011; Chen et al., 2011; Dehmer et al., 2013a). This is particularly
plausible for a complex disorder like cancer, because the hall-
marks of cancer are represented by pathways rather than individ-
ual genes (Hanahan and Weinberg, 2011) and the crucial aspect
of pathways is that their constituting genes are actively interacting
with each other. For this reason, network-based biomarkers can
be seen as statistical measures that consider the interaction struc-
ture between individual genes explicitly. In contrast, biomarkers
based on individual genes neglect these completely. For further
applications of network-based biomarkers see also Dehmer et al.
(2013b).
In the near future, we expect to see similar applications also
for other types of complex disorders, because, despite their differ-
ences among each other, all of them share a need for considering
interaction changes. Unfortunately, developing network-based
biomarkers is considerably more complex than using univariate
and multivariate gene signatures. Also, quantitatively, it remains
to date unclear which gain one should expect from this new type
of biomarkers, if any Staiger et al. (2012).
7.4. COMPARATIVE NETWORK ANALYSIS
When more and more gene regulatory networks from different
physiological and disease conditions become available, it will be
possible to statistically compare these networks (Dehmer and
Emmert-Streib, 2007; Dehmer and Mehler, 2007). This will allow
to learn about interaction changes across different physiological
or disease conditions and enrich our biological and biomedi-
cal understanding of such phenotypes (Ideker and Krogan, 2012;
Islam et al., 2013). Besides using classical comparative measures
such as the graph edit distance or the Zelinka distance, topo-
logical indices could be also employed for such an analysis, see
Dehmer et al. (2013c). It might be challenging to determine
which similarity or distance measures are suitable to perform
such a comparative network analysis and different types of net-
works as well as different biological questions may require dif-
ferent approaches, see (Sharan and Ideker, 2006; Przulj, 2007;
Mithani et al., 2011; Pache and Aloy, 2012) for protein interaction
networks or metabolic networks, for instance.
However, in order for this approach to succeed it will be
necessary to establish databases, similar to sequence or protein
structure databases, that provide free access to the inferred gene
regulatory networks from different physiological and disease con-
ditions. To this end, it may be necessary to form an international
coalition because the expected effort to establish such a database
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and interactive access interfaces is anticipated to be larger than of
sequence databases.
7.5. NETWORK MEDICINE AND DRUG DESIGN
For establishing a network medicine useful for clinicians, it will
be necessary to integrate different types of gene networks with
each other (Shapira et al., 2009; Barabási et al., 2011), because
each network type carries information about particular molecu-
lar aspects. For example, whereas the transcriptional regulatory
network contains only information about the controlling regula-
tions of gene expression, protein interaction networks represent
information about protein-protein complexes. Taken together,
an integration of various important molecular interaction types
results in a comprehensive overview of regulatory programs
and organizational architectures. Also, information about tem-
poral changes in the network structure are important to under-
stand immune response, infection and differentiation processes
(Rozenblatt-Rosen et al., 2012; Yosef et al., 2013).
Also for a more efficient design of rational drugs the utiliza-
tion of gene networks are indispensable (Ghosh and Basu, 2012;
Fortney et al., 2013). For this reason, both subjects would profit
tremendously if there would be more large-scale gene expression
data available together with, e.g., survival data and drug-dose
response information. This would allow to create, e.g., a connec-
tivity map (Lamb et al., 2006) that is based on the similarity of
molecular interaction networks rather than on the mere simi-
larity of expression profiles. Overall, this would help us on our
way to a more personalized medicine (Chan and Ginsburg, 2011),
because condition specific gene regulatory networks are closer to
the phenotype than genetic or epigenetic markers; see Figure 1
for a visualization.
8. KNOWLEDGE PLATFORM FOR MEDICAL AND CLINICAL
PRACTICE
It is important to emphasize that gene regulatory networks are
not the final outcome of a biological or biomedical study, but
an intermediate result. For this reason, interrogation platforms
are needed that allow the downstream analysis of such networks.
Specifically, aside from databases that store inferred GRNs, net-
work analysis tools and visualization layouts are needed that allow
an easy integration with biological and clinical information, e.g.,
in form of GO and KEGG databases or clinical patient and gen-
eral epidemiological data. Such a knowledge platform should
hold cross-disease information similar to the OMIM (Online
Mendelian Inheritance in Man).
Furthermore, it would be desirable if such a knowledge plat-
form has an intuitive to use interface allowing also non-technical
experts the exploration of GRNs. For a practical realization, e.g.,
the tranSMART platform (Athey et al., 2013) could be utilized.
TranSMART is based on the open source i2b2 (informatics for
integrating biology and the bedside) framework, sponsored by
the NIH Roadmap NCBC, to provide clinicians with the tools
to integrate clinical genomics with medical patient record data.
An attractive feature of tranSMART is that it can be combined
with Galaxy, an open, web-based user interface, which allows the
connection to a variety of programming languages. That means
a researcher without specific bioinformatic expertise can utilize
R scripts, e.g., provided by Bioconductor, CRAN or individu-
ally developed packages, via a web-based graphical user inter-
face for analyzing GRNs. Importantly, Galaxy offers also several
mechanisms to ensure the reproducibility of research results.
9. CONCLUSION
In this paper, we discussed important aspects of gene regulatory
networks inferred from gene expression data. Due to the mul-
tifaceted nature of GRNs, for which we gave some examples in
this paper, a discussion about these networks cannot be one-
dimensional because this would give a misleading impression of
their meaning and potential usage. For this reason, we tried to
provide a broad discussion touching upon a variety of differ-
ent aspects to emphasize the intriguing depth offered by gene
regulatory networks.
We think that neither the future of biology nor medicine is
conceivable without gene networks in general, whereas gene regu-
latory networks form an important subtype of these, because such
networks can be seen as a practical embodiment of systems biol-
ogy. However, in order to exploit and utilize such networks effi-
ciently in molecular biology, cellular biology and the biomedical
sciences we need to establish comprehensive databases.
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